TY  - GEN
AU  - Burton,Dennis R
AU  - Desrosiers,Ronald C
AU  - Doms,Robert W
AU  - Feinberg,Mark B
AU  - Gallo,Robert C
AU  - Hahn,Beatrice
AU  - Hoxie,James A
AU  - Hunter,Eric
AU  - Korber,Bette
AU  - Landay,Alan
AU  - Lederman,Michael M
AU  - Lieberman,Judy
AU  - McCune,Joseph M
AU  - Moore,John P
AU  - Nathanson,Neal
AU  - Picker,Louis
AU  - Richman,Douglas
AU  - Rinaldo,Charles
AU  - Stevenson,Mario
AU  - Watkins,David I
AU  - Wolinsky,Steven M
AU  - Zack,Jerome A
TI  - Public health. A sound rationale needed for phase III HIV-1 vaccine trials
SN  - 1095-9203
PY  - 2004///0209
KW  - AIDS Vaccines
KW  - immunology
KW  - Clinical Trials, Phase III as Topic
KW  - economics
KW  - Costs and Cost Analysis
KW  - HIV Envelope Protein gp120
KW  - HIV Infections
KW  - HIV-1
KW  - Humans
KW  - Immunization Schedule
KW  - Immunization, Secondary
KW  - T-Lymphocytes, Cytotoxic
KW  - T-Lymphocytes, Helper-Inducer
KW  - Thailand
KW  - United States
KW  - Vaccines, Synthetic
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1126/science.1094620
ER  -